Bioventus Inc. [•] Shares of Class A Common Stock Underwriting AgreementUnderwriting Agreement • February 4th, 2021 • Bioventus Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledFebruary 4th, 2021 Company Industry JurisdictionBioventus Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [•] shares of Class A common stock, par value $0.001 per share (“Class A Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [•] shares of Class A Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Class A Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
Bioventus Inc. [•] Shares of Class A Common Stock Underwriting AgreementUnderwriting Agreement • July 19th, 2016 • Bioventus Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledJuly 19th, 2016 Company Industry JurisdictionBioventus Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of [•] shares of Class A Common Stock, par value $0.0001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [•] shares of Class A Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Class A Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.